RAF/MEK inhibitor
Advertisement
Dr. Camidge Discusses Launch of Phase 2 Trial Evaluating RAF/MEK Inhibitor in NSCLC
Kaitlyn D’OnofrioNon-Small Cell Lung Cancer | September 21, 2023
Verastem Oncology recently announced the initiation of the second phase 2 registration-directed clinical trial from its ...
View More
Advertisement
Advertisement
Latest News

Study Highlights Relationship Between Lipid Metabolism, NK Cells in the NSCLC Tumor Microenvironment

May 16, 2025

Medicaid Expansion: Study Investigates Impacts on Lung Cancer Surgery

May 15, 2025

FDA Grants Accelerated Approval To Telisotuzumab Vedotin for Certain Patients With NSCLC

May 14, 2025

Officials Announce Topline Results From GALAXIES Lung-201 and Halt Development of Belrestotug

May 13, 2025

Researchers Evaluate Novel Circular RNA Vaccine for Lung Cancer

May 12, 2025

Lung Cancer Action Week: Dr. Gieske Reflects on Screening Advances and Milestones

May 9, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |